Terns Pharmaceuticals Inc (TERN) Stock Analysis

Terns Pharmaceuticals Inc (TERN) is a publicly traded company in the HEALTHCARE sector. It trades at $52.95. This page summarizes the public market data, fundamentals, and frequently asked questions for TERN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $52.95

Market Sentiment

Terns Pharmaceuticals Inc currently has a Neutral sentiment score of 0.10.

About Terns Pharmaceuticals Inc

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Foster City, California, focused on developing innovative small-molecule therapies aimed at treating nonalcoholic steatohepatitis (NASH) and other serious chronic liver diseases. With a robust pipeline of both single-agent and combination therapy candidates, Terns is at the forefront of addressing unmet medical needs in hepatology. The company’s commitment to advancing its clinical programs positions it as a ke...

GNG Research Analysis

GNG Research scores Terns Pharmaceuticals Inc (TERN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TERN.

Frequently Asked Questions

Does TERN pay dividends?

Terns Pharmaceuticals Inc (TERN) does not currently pay a regular dividend.